TrialThe New England journal of medicine2013
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.
J E Cortes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
538 papers cite itlatest 60 shown
this paperpooled ittrialcites it